Evidence map›Paper›PMID 38186223›Full record

ArticleActa biochimica et biophysica Sinica2024

Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.

Zhaoxian Ni, Shan Cong, Hongchang Li, Jiazhe Liu, Qing Zhang, Chuanchao Wei, Gaofeng Pan, Hui He, Weiyan Liu, Anwei Mao

Open access · diamondAbstract read
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zhaoxian NiDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Shan CongDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Hongchang LiDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Jiazhe LiuDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Qing ZhangDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Chuanchao WeiDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Gaofeng PanDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Hui HeDepartment of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Weiyan LiuDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Anwei MaoDepartment of General Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China.
Minhang District Central Hospital · CNFudan University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer (TC) is a kind of cancer with high heterogeneity, which leads to significant difference in prognosis. The prognostic molecular processes are not well understood. Cancer cells and tumor microenvironment (TME) cells jointly determine the heterogeneity. However, quite a little attention was paid to cells in the TME in the past years. In this study, we not only reveal that endothelial cells (ECs) are strongly associated with the progress of papillary thyroid cancer (PTC) using single-cell RNA-seq (scRNA-seq) data downloaded from Gene Expression Omnibus (GEO) and WGCNA, but also screen 5 crucial genes of ECs:

Indexed as

RNA, Small CytoplasmicThyroid NeoplasmsEndothelial CellsHumansPrognosisRNASingle-Cell AnalysisTumor MicroenvironmentRNARNA, Small Cytoplasmicbiomarkerprognosis modulesingle-cell RNA-seqthyroid cancer

Identifiers

PMID38186223
PMCPMC10984871
OpenAlexW4388205649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.